ID

4503

Descrição

ACNS1123 Eligibility Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Palavras-chave

Versões (2)
  1. 09/12/2013 09/12/2013 - Martin Dugas
  2. 02/06/2015 02/06/2015 -
Transferido a

9 de dezembro de 2013

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0 Legacy
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

  • Os mais recentes
  • Os mais antigos
  • Preferidos
  • Os mais recentes
    • Os mais recentes
    • Os mais antigos
    • Preferidos

Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

ACNS1123 Eligibility - 3377519v1.0

Inglês

No Instruction available.

1 Formulários  
  1. StudyEvent: SE.0000
    1. No Instruction available.
Stratification
Descrição

Stratification

ACNS1123 Stratum
Descrição

ClinicalStudyACNS1123StratificationFactorsType

Tipo de dados

text

Study Treatment
Descrição

TreatmentAssignmentType

Tipo de dados

text

Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
Descrição

TreatmentBeginDate

Tipo de dados

date

Elig - Block 1
Descrição

Elig - Block 1

Is the patient enrolled on the ALTE07C1 study?
Descrição

OtherStudyEnrollmentInd-2

Tipo de dados

text

Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
Descrição

PatientAgeEligibilityDeterminationInd-2

Tipo de dados

text

Was definitive diagnostic surgery performed?
Descrição

FirstDiagnosisFromSurgicalProcedureIndicator

Tipo de dados

text

Date of definitive diagnostic surgery or clinical diagnosis:
Descrição

PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate

Tipo de dados

date

Was lumbar CSF cytology obtained?
Descrição

CerebrospinalFluidCellInd-3

Tipo de dados

text

Was it medically contraindicated? (If no,)
Descrição

CerebrospinalFluidDiagnosticProcedureCytologyContraindicatedInd-2

Tipo de dados

text

Was lumbar CSF cytology negative?
Descrição

LaboratoryProcedureLumbarPunctureCerebrospinalFluidNegativeFindingOutcomeInd-2

Tipo de dados

text

Elig - Block 2
Descrição

Elig - Block 2

Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
Descrição

GermCellTumorHistologicClassificationDiagnosisInd-2

Tipo de dados

text

Elig - Block 3
Descrição

Elig - Block 3

Does patient have newly diagnosed localized primary CNS NGGCT?
Descrição

NewPrimaryMalignantNeoplasmCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo de dados

text

Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
Descrição

PathologyFindingsIndicator

Tipo de dados

text

Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
Descrição

PatientProtocolRequirementEligibilityDeterminationInd-2

Tipo de dados

text

Elig - Block 4
Descrição

Elig - Block 4

Does patient have newly diagnosed localized primary CNS germinoma?
Descrição

NewChildhoodBrainGerminomaDiagnosisInd-2

Tipo de dados

text

Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
Descrição

PatientProtocolRequirementEligibilityDeterminationInd-2

Tipo de dados

text

Elig - Block 5
Descrição

Elig - Block 5

Peripheral absolute neutrophil count (ANC) (number/uL)
Descrição

LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue

Tipo de dados

double

Unidades de medida
  • ul
ul
Platelet count (number/uL): (Transfusion Independent)
Descrição

LaboratoryProcedurePlateletResultSpecifiedValue

Tipo de dados

double

Unidades de medida
  • 1000/uL
1000/uL
Hemoglobin(g/dL) (May receive RBC transfusion)
Descrição

LaboratoryProcedureHemoglobinResultSpecifiedValue

Tipo de dados

double

Unidades de medida
  • g/dL
g/dL
Elig - Block 5
Descrição

Elig - Block 5

Creatinine clearance (mL/min/1.73m²):
Descrição

LaboratoryProcedureCreatinineClearanceOutcomeValue

Tipo de dados

double

Radioisotope GFR(mL/min/1.73 m²)
Descrição

LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue

Tipo de dados

double

Unidades de medida
  • mL/Min/1.73m2
mL/Min/1.73m2
Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
Descrição

LaboratoryProcedureCreatinineResultSpecifiedValue

Tipo de dados

double

Unidades de medida
  • mg/dL
mg/dL
Elig - Block 7
Descrição

Elig - Block 7

Total bilirubin (mg/dl), ULN
Descrição

LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue

Tipo de dados

double

Unidades de medida
  • mg/dL
mg/dL
Total bilirubin Value (mg/dl):
Descrição

LaboratoryProcedureTotalBilirubinResultValue

Tipo de dados

double

Unidades de medida
  • mg/dL
mg/dL
SGPT (ALT) or SGOT (AST) U/L, ULN:
Descrição

LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue

Tipo de dados

double

SGPT (ALT) or SGOT (AST), U/L
Descrição

LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue

Tipo de dados

double

Elig - Block 8
Descrição

Elig - Block 8

Does patient have seizure disorder?
Descrição

PatientSeizureDiseaseorDisorderInd-3

Tipo de dados

text

Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
Descrição

NeurologicalEvaluationSeizureSymptomInd-2

Tipo de dados

text

Is patient in status, coma or assisted ventilation at study entry?
Descrição

PatientMechanicalVentilationUseInd-2

Tipo de dados

text

Elig - Block 9
Descrição

Elig - Block 9

Does patient have mature teratoma with normal tumor markers?
Descrição

PatientCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo de dados

text

Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
Descrição

ExternalBrainVentricleCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo de dados

text

Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
Descrição

MetastaticDiseaseorDisorderMagneticResonanceImagingCerebrospinalFluidDiagnosisInd-2

Tipo de dados

text

Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
Descrição

SurgicalInterventionCorticosteroidAdministeredInd-2

Tipo de dados

text

Is patient post menarcheal?
Descrição

PediatricEndocrineMensesOnsetInd-2

Tipo de dados

text

Was a pregnancy test performed?
Descrição

PatientPregnancyTestIndicator

Tipo de dados

text

Is patient pregnant? (If yes above,)
Descrição

PatientPregnancyInd-2

Tipo de dados

text

Is patient nursing?
Descrição

PersonBreastFeedingExclusionCriteriaIndicator

Tipo de dados

text

Has patient agreed to stop breastfeeding? (If yes above,)
Descrição

BreastFeedingStopAgreementInd-4

Tipo de dados

text

Has patient agreed to use an effective contraceptive method for the duration of the study participation?
Descrição

ContraceptionAgreementInd

Tipo de dados

text

Elig - Block 10
Descrição

Elig - Block 10

Date Informed Consent Signed
Descrição

InformedConsentFormSignedDate

Tipo de dados

date

Have all institutional, FDA, and NCI requirements for human studies been met?
Descrição

StudyCompleteRequirementsInd-2

Tipo de dados

text

Comments
Descrição

ResearchCommentsText

Tipo de dados

text

Voltar ao início da página

Similar models

No Instruction available.

1 Formulários
  1. StudyEvent: SE.0000
    1. No Instruction available.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Stratification
CL.1
Code List
ACNS1123 Stratum
CL Item
Stratum 1 - Nggct (Stratum 1 - NGGCT)
CL Item
Stratum 2 - Germinoma (Stratum 2 - Germinoma)
Item
Study Treatment
text
CL.2
Code List
Study Treatment
CL Item
Treatment 1: A,b,a,b,a,b (Treatment 1 A B A B A B)
CL Item
Treatment 2: A,a,a,a (Treatment 2 A A A A)
TreatmentBeginDate
Item
Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
date
Item Group
Elig - Block 1
Item
Is the patient enrolled on the ALTE07C1 study?
text
CL.3
Code List
Is the patient enrolled on the ALTE07C1 study?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
text
CL.4
Code List
Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Was definitive diagnostic surgery performed?
text
CL.5
Code List
Was definitive diagnostic surgery performed?
CL Item
Yes (Yes)
CL Item
No (No)
PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate
Item
Date of definitive diagnostic surgery or clinical diagnosis:
date
Item
Was lumbar CSF cytology obtained?
text
CL.6
Code List
Was lumbar CSF cytology obtained?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Was it medically contraindicated? (If no,)
text
CL.7
Code List
Was it medically contraindicated? (If no,)
CL Item
Yes (Yes)
CL Item
No (No)
CL.8
Code List
Was lumbar CSF cytology negative?
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 2
Item
Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
text
CL.9
Code List
Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 3
Item
Does patient have newly diagnosed localized primary CNS NGGCT?
text
CL.10
Code List
Does patient have newly diagnosed localized primary CNS NGGCT?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
text
CL.11
Code List
Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
CL Item
Yes (YES)
CL Item
No (NO)
Item
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
text
CL.14
Code List
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have newly diagnosed localized primary CNS germinoma?
text
CL.13
Code List
Does patient have newly diagnosed localized primary CNS germinoma?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
text
CL.14
Code List
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
CL Item
Yes (Yes)
CL Item
No (No)
LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue
Item
Peripheral absolute neutrophil count (ANC) (number/uL)
double
LaboratoryProcedurePlateletResultSpecifiedValue
Item
Platelet count (number/uL): (Transfusion Independent)
double
LaboratoryProcedureHemoglobinResultSpecifiedValue
Item
Hemoglobin(g/dL) (May receive RBC transfusion)
double
LaboratoryProcedureCreatinineClearanceOutcomeValue
Item
Creatinine clearance (mL/min/1.73m²):
double
LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue
Item
Radioisotope GFR(mL/min/1.73 m²)
double
LaboratoryProcedureCreatinineResultSpecifiedValue
Item
Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
double
LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue
Item
Total bilirubin (mg/dl), ULN
double
LaboratoryProcedureTotalBilirubinResultValue
Item
Total bilirubin Value (mg/dl):
double
LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue
Item
SGPT (ALT) or SGOT (AST) U/L, ULN:
double
LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue
Item
SGPT (ALT) or SGOT (AST), U/L
double
Item Group
Elig - Block 8
Item
Does patient have seizure disorder?
text
CL.15
Code List
Does patient have seizure disorder?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
text
CL.16
Code List
Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient in status, coma or assisted ventilation at study entry?
text
CL.17
Code List
Is patient in status, coma or assisted ventilation at study entry?
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 9
Item
Does patient have mature teratoma with normal tumor markers?
text
CL.18
Code List
Does patient have mature teratoma with normal tumor markers?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
text
CL.19
Code List
Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
text
CL.20
Code List
Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
text
CL.21
Code List
Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient post menarcheal?
text
CL.22
Code List
Is patient post menarcheal?
CL Item
Yes (yes)
CL Item
No (no)
Item
Was a pregnancy test performed?
text
CL.23
Code List
Was a pregnancy test performed?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient pregnant? (If yes above,)
text
CL.24
Code List
Is patient pregnant? (If yes above,)
CL Item
Yes (Yes)
CL Item
No (No)
CL.25
Code List
Is patient nursing?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Has patient agreed to stop breastfeeding? (If yes above,)
text
CL.26
Code List
Has patient agreed to stop breastfeeding? (If yes above,)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Has patient agreed to use an effective contraceptive method for the duration of the study participation?
text
CL.27
Code List
Has patient agreed to use an effective contraceptive method for the duration of the study participation?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/a, Patient Is Not Of Reproductive Potential (NA patient is not of reproductive potential)
Item Group
Elig - Block 10
InformedConsentFormSignedDate
Item
Date Informed Consent Signed
date
Item
Have all institutional, FDA, and NCI requirements for human studies been met?
text
CL.28
Code List
Have all institutional, FDA, and NCI requirements for human studies been met?
CL Item
Yes (Yes)
CL Item
No (No)
ResearchCommentsText
Item
Comments
text
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial